Patysheva, Marina R.
Kolegova, Elena S.
Khozyainova, Anna A.
Prostakishina, Elizaveta A.
Korobeynikov, Vyacheslav Y.
Menyailo, Maxim E.
Iamshchikov, Pavel S.
Loos, Dmitry M.
Kovalev, Oleg I.
Zavyalova, Marina V.
Fedorova, Irina K.
Kulbakin, Denis E.
Larionova, Irina V.
Polyakov, Andrey P.
Yakovleva, Liliya P.
Kropotov, Mikhail A.
Sukortseva, Natalya S.
Lu, Yusheng
Jia, Lee
Arora, Rohit
Choinzonov, Evgeny L.
Bose, Pinaki
,
Denisov, Evgeny V.
Funding for this research was provided by:
Russian Science Foundation (22-15-00308)
Article History
Received: 22 March 2024
Accepted: 10 October 2024
First Online: 1 November 2024
Competing interests
: The authors declare no competing interests.
: The study was approved by the Ethics Committee of the Cancer Research Institute of Tomsk National Research Medical Center of the Russian Academy of Sciences (Study ID: No. 12 of 15 June 2022) and Health Research Ethics Board of Alberta – Cancer Committee (Study ID: HREBA.CC-16–0644) and performed according to the guidelines of Declaration of Helsinki and the International Conference on Harmonization’s Good Clinical Practice Guidelines (ICH GCP). All subjects gave written informed consent in accordance with the Declaration of Helsinki.